₹22,038.7
(110.1)
(0.5%)
30 Jun , 2025 | 04:14 PM
Open
₹22,036.25
Prev. Close
₹21,928.6
Market Cap.
₹16,90,903.71
Div Yield
0.75
PE
31.35
PB
31.35
₹21,934.2
₹22,079.1
Performance
One Week (%)
1.46
One Month (%)
1.87
One Year (%)
12.36
YTD (%)
5.56
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 35,670 | 35,790 | 34,140 | 25,043 |
Cipla Ltd | 1,505.9 | 1,514.7 | 1,500.2 | 10,53,681 |
J B Chemicals & Pharmaceuticals Ltd | 1,679.3 | 1,705 | 1,673 | 12,61,603 |
Dr Reddys Laboratories Ltd | 1,283.3 | 1,305 | 1,272.5 | 22,24,279 |
Lupin Ltd | 1,938 | 1,961.9 | 1,925 | 7,47,414 |
Torrent Pharmaceuticals Ltd | 3,408.2 | 3,478.9 | 3,322 | 22,10,845 |
Ipca Laboratories Ltd | 1,389.8 | 1,397 | 1,331.7 | 3,35,012 |
Sun Pharmaceutical Industries Ltd | 1,675.7 | 1,704.5 | 1,671.6 | 21,60,184 |
Aurobindo Pharma Ltd | 1,134.8 | 1,159.9 | 1,130 | 16,53,812 |
Natco Pharma Ltd | 926.65 | 932.5 | 891.9 | 23,18,224 |
Granules India Ltd | 495.3 | 499.75 | 493 | 4,80,217 |
Ajanta Pharma Ltd | 2,574.1 | 2,584.1 | 2,543.2 | 1,31,475 |
Gland Pharma Ltd | 1,833.6 | 1,844 | 1,781.4 | 3,99,506 |
Biocon Ltd | 355.7 | 356.6 | 349.55 | 26,37,925 |
Alkem Laboratories Ltd | 4,939 | 4,943.5 | 4,902.5 | 71,583 |
Glenmark Pharmaceuticals Ltd | 1,753.8 | 1,758.2 | 1,715.4 | 9,25,571 |
Zydus Lifesciences Ltd | 989.95 | 991 | 978.7 | 8,18,854 |
Divis Laboratories Ltd | 6,809.5 | 6,829 | 6,666 | 5,99,664 |
Mankind Pharma Ltd | 2,319.8 | 2,349 | 2,310.1 | 2,42,516 |
Laurus Labs Ltd | 724.85 | 727 | 704 | 48,37,432 |
The company plans to develop a residential plotted township on the site and expects to generate revenue of over ₹1,250 crore through plot sales.
30 Jun 2025|04:29 PM
Alembic Pharmaceuticals shares have gained 10% in the last year, dipped 2.8% in the year-to-date, and gained 2.3% in the previous month.
30 Jun 2025|04:17 PM
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
30 Jun 2025|04:04 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
